• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease-author's reply.

作者信息

McCurdy Jeffrey D

机构信息

University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

出版信息

Aliment Pharmacol Ther. 2019 Sep;50(6):714-715. doi: 10.1111/apt.15457.

DOI:10.1111/apt.15457
PMID:31456301
Abstract
摘要

相似文献

1
Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease-author's reply.
Aliment Pharmacol Ther. 2019 Sep;50(6):714-715. doi: 10.1111/apt.15457.
2
Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 2019 Sep;50(6):712-713. doi: 10.1111/apt.15411.
3
Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2020 Apr 11;26(5):e45. doi: 10.1093/ibd/izaa051.
4
Increased Risk of Venous Thromboembolic Events With Corticosteroid Versus Biologic Therapy for Inflammatory Bowel Disease.与生物制剂治疗炎症性肠病相比，使用皮质类固醇治疗炎症性肠病会增加静脉血栓栓塞事件的风险。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):166-7. doi: 10.1016/j.cgh.2015.04.022. Epub 2015 Apr 27.
5
Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
Inflamm Bowel Dis. 2020 May 12;26(6):e48. doi: 10.1093/ibd/izaa050.
6
Editorial: avoiding corticosteroids in the treatment of inflammatory bowel disease-Author's reply.社论：炎症性肠病治疗中避免使用皮质类固醇——作者回复
Aliment Pharmacol Ther. 2018 Jan;47(1):145. doi: 10.1111/apt.14403.
7
Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Diseases-Authors' Reply.
J Crohns Colitis. 2023 Mar 18;17(2):306. doi: 10.1093/ecco-jcc/jjac162.
8
Letter: different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases - authors' reply.信函：炎症性肠病患者亚组中静脉血栓栓塞的不同风险——作者回复
Aliment Pharmacol Ther. 2019 Feb;49(3):346. doi: 10.1111/apt.15103.
9
Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.抗肿瘤坏死因子-α治疗与炎症性肠病住院患者血栓栓塞事件风险降低相关。
J Clin Gastroenterol. 2016 Aug;50(7):578-83. doi: 10.1097/MCG.0000000000000408.
10
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease.与生物治疗相比，皮质类固醇治疗炎症性肠病会增加静脉血栓栓塞事件的风险。
Clin Gastroenterol Hepatol. 2015 Feb;13(2):316-21. doi: 10.1016/j.cgh.2014.07.017. Epub 2014 Jul 17.